These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4723698)

  • 21. Ischemic heart disease: a secondary prevention trial using clofibrate (Atromid-S).
    Oliver MF
    Adv Exp Med Biol; 1972; 26(0):255-9. PubMed ID: 4679687
    [No Abstract]   [Full Text] [Related]  

  • 22. Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials.
    Drug Ther Bull; 1972 Aug; 10(17):65-6. PubMed ID: 4570864
    [No Abstract]   [Full Text] [Related]  

  • 23. Weight and weight history in relation to cerebrovascular and ischemic heart disease.
    Heyden S; Hames CG; Bartel A; Cassel JC; Tyroler HA; Cornoni JC
    Arch Intern Med; 1971 Dec; 128(6):956-60. PubMed ID: 5132455
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of hypercholesterolemia with beta-pyridylcarbinol. Experiences after long term treatment over 8 years (author's transl)].
    Zöllner N; Keller C; Wolfram G
    Med Klin; 1976 Apr; 71(18):768-74. PubMed ID: 818496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined coronary-cerebral disorders in patients with ischemic heart disease].
    Laufer MIa; Sharapova MD; Klushin DF; Kartmazova KM; Mirlin BG
    Kardiologiia; 1971; 11(4):68-75. PubMed ID: 5096584
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: The value of clofibrate in coronary heart disease.
    Gillam PM
    Am Heart J; 1974 Jan; 87(1):1-4. PubMed ID: 4808754
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of long-term administration of clofibrate on the composition of blood lipids in patients with atherosclerosis.
    Poleszak J; Korolko A
    Pol Med J; 1972; 11(2):250-6. PubMed ID: 5071512
    [No Abstract]   [Full Text] [Related]  

  • 29. Clofibrate in ischemic heart disease.
    Friedewald WT; Halperin M
    Ann Intern Med; 1972 May; 76(5):821-3. PubMed ID: 5025329
    [No Abstract]   [Full Text] [Related]  

  • 30. [Statistics for the study of cerebrovascular insufficiency due to occlusive or stenotic lesions of the middle cerebral artery. II].
    Tedeschi G; Signorelli CD; De Divitiis E
    Rass Int Clin Ter; 1971 May; 51(9):543-9. PubMed ID: 5555743
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 32. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 33. Cooperative clofibrate trial.
    Vaisrub S
    JAMA; 1979 Jun; 241(24):2638. PubMed ID: 374769
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduced incidence of cardiovascular complications and mortality in hyperlipoproteinemia (HLP) with effective lipid correction. The Dresden HLP study.
    Hanefeld M; Hora C; Schulze J; Rothe G; Barthel U; Haller H
    Atherosclerosis; 1984 Oct; 53(1):47-58. PubMed ID: 6497944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group.
    JAMA; 1972 May; 220(7):996-1008. PubMed ID: 4337170
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of clofibrate on serum and faecal lipids.
    Mitchell WD; Murchison LE
    Clin Chim Acta; 1972 Jan; 36(1):153-61. PubMed ID: 5007696
    [No Abstract]   [Full Text] [Related]  

  • 37. [Hyperlipemia as a risk factor in ischemic heart disease].
    Hashimoto T; Kobayashi M; Igarashi H; Niitani H
    Nihon Rinsho; 1975 Nov; 33(11):3179-84. PubMed ID: 1107622
    [No Abstract]   [Full Text] [Related]  

  • 38. Clofibrate and coronary heart disease.
    Med J Aust; 1972 Jan; 1(4):145-7. PubMed ID: 4551814
    [No Abstract]   [Full Text] [Related]  

  • 39. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
    Zelis R; Amsterdam EA; Spann JF; Mason DT
    JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727
    [No Abstract]   [Full Text] [Related]  

  • 40. Transient ischemic attacks (TIAS) and cerebral infarction (CI): a comparison of predisposing factors.
    Ueda K; Howard G; Toole JF
    J Chronic Dis; 1980; 33(1):13-9. PubMed ID: 7356671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.